- Filed
- Feb 28, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Cash And Equivalents | Q1 2025 · Jan 31, 2025 | $165.47M |
| Cash And Equivalents | Q1 2025 · Oct 31, 2024 | $162.1M |
| Stockholders Equity | Q1 2025 · Jan 31, 2025 | $3.75B |
| Stockholders Equity | Q1 2025 · Oct 31, 2024 | $3.64B |
| Current Liabilities | Q1 2025 · Jan 31, 2025 | $618.34M |
| Current Liabilities | Q1 2025 · Oct 31, 2024 | $663.85M |
| Total Liabilities | Q1 2025 · Jan 31, 2025 | $3.66B |
| Total Liabilities | Q1 2025 · Oct 31, 2024 | $3.53B |
| Current Assets | Q1 2025 · Jan 31, 2025 | $2.1B |
| Current Assets | Q1 2025 · Oct 31, 2024 | $2.06B |
| Total Assets | Q1 2025 · Jan 31, 2025 | $7.89B |
| Total Assets | Q1 2025 · Oct 31, 2024 | $7.59B |
| Shares Diluted | Q1 2025 · Jan 31, 2024 | 139.89M sh |
| Dividends Paid | Q1 2025 · Jan 31, 2024 | $13.83M |
| Capex | Q1 2025 · Jan 31, 2024 | $13.38M |
| Operating Cash Flow | Q1 2025 · Jan 31, 2024 | $111.65M |
| Eps Diluted | Q1 2025 · Jan 31, 2024 | $0.82 |
| Eps Basic | Q1 2025 · Jan 31, 2024 | $0.83 |
| Sga Expense | Q1 2025 · Jan 31, 2024 | $166.56M |
| Net Income | Q1 2025 · Jan 31, 2024 | $114.7M |
| Operating Income | Q1 2025 · Jan 31, 2024 | $180.21M |
| Cost Of Revenue | Q1 2025 · Jan 31, 2024 | $549.59M |
| Revenue | Q1 2025 · Jan 31, 2024 | $896.36M |
| Rd Expense restated | Q1 2025 · Jan 31, 2023 | $25.1M |